We've found
11,571 Blood Cancer
clinical trials
Hematology, Oncology Clinical Trial
CPX-351 and Enasidenib in Treating Patients With Relapsed Acute Myeloid Leukemia Characterized by IDH2 Mutation
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
CPX-351 and Enasidenib in Treating Patients With Relapsed Acute Myeloid Leukemia Characterized by IDH2 Mutation
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts
Status: Upcoming
Updated: 11/5/2012
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders
Status: Upcoming
Updated: 1/23/2013
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Dovitinib Combined With Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma
Status: Upcoming
Updated: 9/4/2012
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status: Upcoming,
Phase
II
Updated: 9/13/2013
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic Syndrome
Status: Upcoming,
Phase
II
Updated: 2/2/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Efficacy and Safety of CTL019 in Adult ALL Patients
Status: Upcoming,
Phase
II
Updated: 9/29/2015
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma
Status: Upcoming,
Phase
I, II
Updated: 1/7/2016
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Bendamustine Hydrochloride in Treating Patients With Previously Treated Multiple Myeloma
Status: Upcoming,
Phase
I
Updated: 4/11/2016
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
GO-203-2C + Bortezomib For Relapsed Or Refractory MM
Status: Upcoming,
Phase
I
Updated: 7/27/2016
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma
Status: Upcoming,
Phase
I
Updated: 9/13/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML
Status: Upcoming
Updated: 8/24/2017
Click here to add this to my saved trials
Childhood Acute Lymphoblastic Leukemia in Remission Clinical Trial
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia in First Remission
Status: Upcoming
Updated: 7/31/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Guadecitabine Extension Study
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Leukemia Clinical Trial
Pilot Imaging Study of Leukemia
Status: Upcoming,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
TK216 and Decitabine in Treating Patients With Relapsed and Refractory Acute Myeloid Leukemia
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK Inhibitor
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Myelodysplastic Syndromes Clinical Trial
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.
Status: Upcoming,
Phase
I, II
Updated: 12/17/2012
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma
Status: Upcoming,
Phase
II
Updated: 1/14/2014
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Sulindac for Patients With AML
Status: Upcoming,
Phase
II
Updated: 4/25/2013
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
A Single Agent Study to Evaluate the Overall Response Rate, Safety and Tolerability of Orally Administered Vemurafenib
Status: Upcoming,
Phase
I, II
Updated: 4/14/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation
Status: Upcoming,
Phase
II
Updated: 12/2/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)
Status: Upcoming,
Phase
Updated: 2/2/2016
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
GO-203-2C + Bortezomib For Relapsed Or Refractory MM
Status: Upcoming,
Phase
I
Updated: 7/27/2016
Click here to add this to my saved trials
Myelodysplastic Syndromes Clinical Trial
iCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic Syndromes
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Cytokine-Treated Veto Cells in Treating Participants With Hematologic Malignancies Following Stem Cell Transplant
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Guadecitabine Extension Study
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Guadecitabine Extension Study
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukaemia Clinical Trial
Phase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Enasidenib as Maintenance Therapy in Treating Patients With Acute Myeloid Leukemia With IDH2 Mutation After Donor Stem Cell Transplant
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation in Patients With Hematologic Malignancy
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematologic Malignancy Clinical Trial
Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Feasibility of Partners in Care Program for Caregivers of Patients With Acute Myeloid Leukemia
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Lenalidomide Adherence in Older Adults
Status: Upcoming,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab Intravenous (Dara-IV)
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
CPX-351+GO in Subjects 55 Years Old, or Older, With AML
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Analyses of Human Samples Collected in Clinical Trials
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
II
Updated: 11/10/2015
Click here to add this to my saved trials
Pediatric Acute Myelogenous Leukemia (AML) Clinical Trial
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Status: Enrolling
Updated: 12/6/2012
Click here to add this to my saved trials
Pediatric Acute Myelogenous Leukemia (AML) Clinical Trial
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Status: Enrolling
Updated: 12/6/2012
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 3/30/2018
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Oncology Clinical Trial
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Lymphocytic Leukemia, Chronic Clinical Trial
A Study Comparing RO5072759 (GA101) 1000 mg Versus 2000 mg in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GAGE)
Status: Enrolling
Updated: 6/14/2012
Click here to add this to my saved trials
Lymphocytic Leukemia, Chronic Clinical Trial
A Study Comparing RO5072759 (GA101) 1000 mg Versus 2000 mg in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GAGE)
Status: Enrolling
Updated: 6/14/2012
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/2A Dose Escalation Study in CLL, SLL or NHL
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/2A Dose Escalation Study in CLL, SLL or NHL
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/2A Dose Escalation Study in CLL, SLL or NHL
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/2A Dose Escalation Study in CLL, SLL or NHL
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/2A Dose Escalation Study in CLL, SLL or NHL
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Phase 1/2A Dose Escalation Study in CLL, SLL or NHL
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
11,571 Blood Cancer
clinical trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
CPX-351 and Enasidenib in Treating Patients With Relapsed Acute Myeloid Leukemia Characterized by IDH2 Mutation
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
CPX-351 and Enasidenib in Treating Patients With Relapsed Acute Myeloid Leukemia Characterized by IDH2 Mutation
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 11/5/2012
Ex-Vivo Depletion of Myeloma Cells From Peripheral Blood Progenitor Cell Grafts
Status: Upcoming
Updated: 11/5/2012
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 1/23/2013
Study of Phenethyl Isothiocyanate in Lymphoproliferative Disorders
Status: Upcoming
Updated: 1/23/2013
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 9/4/2012
Dovitinib Combined With Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma
Status: Upcoming
Updated: 9/4/2012
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
Updated: 9/13/2013
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status: Upcoming,
Phase
II
Updated: 9/13/2013
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 2/2/2015
Safety and Effectiveness Study of CPI-613 to Treat Refractory or Relapsed Leukemia and Myelodysplastic Syndrome
Status: Upcoming,
Phase
II
Updated: 2/2/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 9/29/2015
Study of Efficacy and Safety of CTL019 in Adult ALL Patients
Status: Upcoming,
Phase
II
Updated: 9/29/2015
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 1/7/2016
Rituximab, Romidepsin, and Lenalidomide in Treating Patients With Recurrent or Refractory B-cell Non-Hodgkin Lymphoma
Status: Upcoming,
Phase
I, II
Updated: 1/7/2016
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 4/11/2016
Bendamustine Hydrochloride in Treating Patients With Previously Treated Multiple Myeloma
Status: Upcoming,
Phase
I
Updated: 4/11/2016
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 7/27/2016
GO-203-2C + Bortezomib For Relapsed Or Refractory MM
Status: Upcoming,
Phase
I
Updated: 7/27/2016
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 9/13/2017
Study of Lenalidomide/Dexamethasone With Nivolumab and Ipilimumab in Patients With Newly Diagnosed Multiple Myeloma
Status: Upcoming,
Phase
I
Updated: 9/13/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 8/24/2017
iCare3: Monitoring Circulating Cancer DNA After Chemotherapy in MDS and AML
Status: Upcoming
Updated: 8/24/2017
Click here to add this to my saved trials
Childhood Acute Lymphoblastic Leukemia in Remission Clinical Trial
Updated: 7/31/2017
Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Newly Diagnosed Acute Lymphoblastic Leukemia in First Remission
Status: Upcoming
Updated: 7/31/2017
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Expanded/Activated Gamma Delta T-cell Infusion Following Hematopoietic Stem Cell Transplantation and Post-transplant Cyclophosphamide
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Guadecitabine Extension Study
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Leukemia Clinical Trial
Updated: 12/31/1969
Pilot Imaging Study of Leukemia
Status: Upcoming,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
TK216 and Decitabine in Treating Patients With Relapsed and Refractory Acute Myeloid Leukemia
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
Dendritic Cell (DC)/Myeloma Fusions in Combination With Nivolumab in Patients With Relapsed Multiple Myeloma
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Trabectedin and Venetoclax in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Resistant or Intolerant to a BTK Inhibitor
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Myelodysplastic Syndromes Clinical Trial
Updated: 12/31/1969
A Study of LB-100 in Patients With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Study of CG-806 in Patients With Relapsed or Refractory CLL/SLL or Non-Hodgkin's Lymphomas
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Myeloid Leukemia Clinical Trial
Updated: 12/17/2012
RAD001 in Patients With Chronic Phase Chronic Myeloid Leukemia w/ Molecular Disease.
Status: Upcoming,
Phase
I, II
Updated: 12/17/2012
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 1/14/2014
MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma
Status: Upcoming,
Phase
II
Updated: 1/14/2014
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Updated: 4/25/2013
Sulindac for Patients With AML
Status: Upcoming,
Phase
II
Updated: 4/25/2013
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 4/14/2014
A Single Agent Study to Evaluate the Overall Response Rate, Safety and Tolerability of Orally Administered Vemurafenib
Status: Upcoming,
Phase
I, II
Updated: 4/14/2014
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/2/2014
Sotrastaurin Acetate in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Leukemia, Prolymphocytic Leukemia, or Richter's Transformation
Status: Upcoming,
Phase
II
Updated: 12/2/2014
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 2/2/2016
Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)
Status: Upcoming,
Phase
Updated: 2/2/2016
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 7/27/2016
GO-203-2C + Bortezomib For Relapsed Or Refractory MM
Status: Upcoming,
Phase
I
Updated: 7/27/2016
Click here to add this to my saved trials
Myelodysplastic Syndromes Clinical Trial
Updated: 12/31/1969
iCare 2: Personalized Genomic Mutation Informed Treatment of Patients With Myelodysplastic Syndromes
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Cytokine-Treated Veto Cells in Treating Participants With Hematologic Malignancies Following Stem Cell Transplant
Status: Upcoming,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Guadecitabine Extension Study
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Guadecitabine Extension Study
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 12/31/1969
Bendamustine/Rituximab Followed by Venetoclax and Rituximab for Treatment of Chronic Lymphocytic Leukemia
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukaemia Clinical Trial
Updated: 12/31/1969
Phase I Dose Escalation Study of Intravenously Administered S64315 in Combination With Orally Administered Venetoclax in Patients With Acute Myeloid Leukaemia
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Enasidenib as Maintenance Therapy in Treating Patients With Acute Myeloid Leukemia With IDH2 Mutation After Donor Stem Cell Transplant
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation in Patients With Hematologic Malignancy
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematologic Malignancy Clinical Trial
Updated: 12/31/1969
Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Feasibility of Partners in Care Program for Caregivers of Patients With Acute Myeloid Leukemia
Status: Upcoming
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients With Recurrent Blood Cancers After Stem Cell Transplant
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
Lenalidomide Adherence in Older Adults
Status: Upcoming,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Updated: 12/31/1969
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 12/31/1969
Daratumumab Retreatment in Participants With Multiple Myeloma Who Have Been Previously Treated With Daratumumab Intravenous (Dara-IV)
Status: Upcoming,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Acute Myeloid Leukemia Clinical Trial
Updated: 12/31/1969
CPX-351+GO in Subjects 55 Years Old, or Older, With AML
Status: Upcoming,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Oncology Clinical Trial
Updated: 12/31/1969
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Analyses of Human Samples Collected in Clinical Trials
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
Updated: 12/31/1969
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Hematology, Immunology / Infectious Diseases, Oncology, Pharmacology / Toxicology, Reproductive Clinical Trial
Updated: 12/31/1969
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 11/10/2015
Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
II
Updated: 11/10/2015
Click here to add this to my saved trials
Pediatric Acute Myelogenous Leukemia (AML) Clinical Trial
Updated: 12/6/2012
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Status: Enrolling
Updated: 12/6/2012
Click here to add this to my saved trials
Pediatric Acute Myelogenous Leukemia (AML) Clinical Trial
Updated: 12/6/2012
Efficacy and Safety of Decitabine as Epigenetic Priming With Induction Chemotherapy in Pediatric Acute Myelogenous Leukemia (AML) Subjects
Status: Enrolling
Updated: 12/6/2012
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 3/30/2018
Carfilzomib, Pomalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling,
Phase
I, II
Updated: 3/30/2018
Click here to add this to my saved trials
Multiple Myeloma Clinical Trial
Updated: 4/24/2017
Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma
Status: Enrolling
Updated: 4/24/2017
Click here to add this to my saved trials
Hematology, Oncology, Other Clinical Trial
Updated: 2/5/2018
Expanded Access Program of Ponatinib
Status: Enrolling
Updated: 2/5/2018
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials
Lymphocytic Leukemia, Chronic Clinical Trial
Updated: 6/14/2012
A Study Comparing RO5072759 (GA101) 1000 mg Versus 2000 mg in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GAGE)
Status: Enrolling
Updated: 6/14/2012
Click here to add this to my saved trials
Lymphocytic Leukemia, Chronic Clinical Trial
Updated: 6/14/2012
A Study Comparing RO5072759 (GA101) 1000 mg Versus 2000 mg in Patients With Previously Untreated Chronic Lymphocytic Leukemia (GAGE)
Status: Enrolling
Updated: 6/14/2012
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 11/2/2015
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 11/2/2015
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Chronic Lymphocytic Leukemia Clinical Trial
Updated: 11/2/2015
An Expanded Access, Open-Label Study of Obinutuzumab (GA101) Plus Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia
Status: Enrolling,
Phase
IV
Updated: 11/2/2015
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Phase 1/2A Dose Escalation Study in CLL, SLL or NHL
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Phase 1/2A Dose Escalation Study in CLL, SLL or NHL
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Phase 1/2A Dose Escalation Study in CLL, SLL or NHL
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Phase 1/2A Dose Escalation Study in CLL, SLL or NHL
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Phase 1/2A Dose Escalation Study in CLL, SLL or NHL
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology Clinical Trial
Updated: 12/31/1969
Phase 1/2A Dose Escalation Study in CLL, SLL or NHL
Status: Enrolling,
Phase
I, II
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Updated: 12/31/1969
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Updated: 12/31/1969
Connect® MDS/AML Disease Registry
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials